Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study

Publication Date

2024

Content Type

article

PubMed ID:

38475923

Additional Authors:

Additional Authors and Institutional Affiliations

This document is currently not available here.

Share

COinS